Researchers drill down on genetic profiles to guide treatment for leukemia patients

Cancer researchers are making strides in efforts to use genetic profiling to develop a more precise understanding of the ...

Cullinan Therapeutics Touts 2026 “Defining Year” as T-Cell Engager, Zipalertinib Catalysts Near

Cullinan Therapeutics (NASDAQ:CGEM) executives highlighted multiple upcoming catalysts across the company’s oncology and ...

Latino father goes viral seeking donors for his son who needs a blood stem cell transplant

Without treatment, Max Uribe faces a high risk of developing life-threatening blood cancers. His father, Juan Uribe, turned ...
Technology Networks

Preventing Stem Cells From Turning Into Cancer Cells

New findings reveal that succinate signaling through SUCNR1 acts as a protective brake in acute myeloid leukemia. Modulating ...
Harvard Medical School

Leonard Zon Receives March of Dimes Richard B. Johnston Jr., MD Prize

Leonard Zon, professor of stem cell and regenerative biology and Grousbeck Professor of Pediatrics at Harvard Medical School, has been awarded the 2026 March of Dimes Richard B. Johnston Jr., MD Prize ...

Everyone Is Mad About James Van Der Beek’s GoFundMe. I Donated to It.

When the Van Der Beek GoFundMe hit half a million dollars, the goal was raised to a million, then a million and a half. The ...

Why Does James Van Der Beek’s Widow Need a GoFundMe?

When the Van Der Beek GoFundMe hit half a million dollars, the goal was raised to a million, then a million and a half. The total donations are climbing toward $3 million at the time of this writing.
PharmiWeb

Faron Announces Phase II BEAM-X IIT Led by the Nordic AML Group Evaluating Bexmarilimab in Post-Transplant AML

Trial investigates macrophage re-reprogramming immunotherapy bexmarilimab in combination with azacitidine to prevent relapse in MRD-positive AML after stem cell transplantation. TURKU, FI / ACCESS ...

Faron Pharmaceuticals: Faron Announces Phase II BEAM-X IIT Led by the Nordic AML Group Evaluating Bexmarilimab in Post-Transplant AML

Trial investigates macrophage re-reprogramming immunotherapy bexmarilimab in combination with azacitidine to prevent relapse in MRD-positive AML after stem cell transplantation. TURKU, FI / ACCESS New ...
CURE

How Orca-T May Transform Blood Cancer Treatment During Transplant

As treatment options for acute myeloid leukemia (AML) evolve, new therapies could change the patient experience around allogeneic stem cell transplant. CURE sat down with Dr. Gwen Nichols, chief ...

James R. Downing, MD, to step down as president and CEO of St. Jude Children's Research Hospital in late 2026

After leading an unprecedented growth of St. Jude Children's Research Hospital over the past 12 years, James R. Downing, MD, will step down as president and CEO in late 2026 as part of a planned ...

SAVE America, or make it harder for Americans to vote? The Wake Up for Thursday, Feb. 19, 2026

Subscribe to the Wake Up, cleveland.com’s free morning newsletter, delivered to your inbox weekdays at 5:30 a.m. I didn’t change my name when I got married. But 70 million American women have, and ...